Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diet, Mediterranean | 36 | 2024 | 740 | 8.840 |
Why?
|
Obesity, Abdominal | 17 | 2024 | 374 | 5.210 |
Why?
|
Weight Loss | 45 | 2024 | 2684 | 4.820 |
Why?
|
Araceae | 7 | 2024 | 19 | 4.210 |
Why?
|
Diet, Fat-Restricted | 18 | 2022 | 329 | 2.690 |
Why?
|
Wine | 5 | 2019 | 166 | 2.270 |
Why?
|
Dyslipidemias | 8 | 2022 | 868 | 2.120 |
Why?
|
Obesity | 45 | 2024 | 12947 | 2.070 |
Why?
|
Abdominal Fat | 4 | 2017 | 221 | 1.900 |
Why?
|
Diet, Reducing | 15 | 2022 | 485 | 1.790 |
Why?
|
Diet, Carbohydrate-Restricted | 13 | 2022 | 262 | 1.780 |
Why?
|
Intra-Abdominal Fat | 12 | 2024 | 613 | 1.710 |
Why?
|
Tea | 7 | 2024 | 288 | 1.610 |
Why?
|
Israel | 31 | 2024 | 726 | 1.600 |
Why?
|
Life Style | 21 | 2024 | 3917 | 1.380 |
Why?
|
Adiposity | 11 | 2024 | 1878 | 1.340 |
Why?
|
Diabetes Mellitus, Type 2 | 26 | 2024 | 12148 | 1.330 |
Why?
|
Plant Proteins | 2 | 2020 | 370 | 1.140 |
Why?
|
Plant Extracts | 2 | 2020 | 498 | 1.060 |
Why?
|
Triglycerides | 13 | 2021 | 2461 | 1.030 |
Why?
|
Adipose Tissue | 10 | 2023 | 3312 | 0.980 |
Why?
|
Juglans | 2 | 2022 | 45 | 0.970 |
Why?
|
Postprandial Period | 4 | 2024 | 315 | 0.940 |
Why?
|
Exercise | 18 | 2023 | 5890 | 0.920 |
Why?
|
Dietary Carbohydrates | 7 | 2017 | 891 | 0.920 |
Why?
|
Nutritional Physiological Phenomena | 3 | 2020 | 363 | 0.900 |
Why?
|
Blood Glucose | 14 | 2024 | 6391 | 0.900 |
Why?
|
Lipids | 10 | 2024 | 3341 | 0.900 |
Why?
|
Basal Metabolism | 3 | 2016 | 161 | 0.900 |
Why?
|
Energy Intake | 12 | 2019 | 2134 | 0.820 |
Why?
|
Body Fat Distribution | 2 | 2021 | 245 | 0.790 |
Why?
|
Coronary Disease | 11 | 2011 | 5914 | 0.740 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36426 | 0.720 |
Why?
|
Weight Gain | 5 | 2023 | 2348 | 0.720 |
Why?
|
Middle Aged | 87 | 2024 | 220895 | 0.700 |
Why?
|
Waist Circumference | 9 | 2020 | 935 | 0.700 |
Why?
|
Ghrelin | 1 | 2022 | 252 | 0.690 |
Why?
|
Feeding Behavior | 13 | 2011 | 3188 | 0.690 |
Why?
|
Fatty Liver | 3 | 2022 | 790 | 0.660 |
Why?
|
Diet | 17 | 2023 | 8075 | 0.630 |
Why?
|
Alcohol Dehydrogenase | 2 | 2015 | 111 | 0.610 |
Why?
|
Vitamin B 12 | 1 | 2020 | 524 | 0.580 |
Why?
|
Dietary Supplements | 3 | 2020 | 3415 | 0.580 |
Why?
|
Body Mass Index | 31 | 2024 | 12953 | 0.560 |
Why?
|
Adult | 80 | 2024 | 221177 | 0.550 |
Why?
|
Male | 95 | 2024 | 360804 | 0.540 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 343 | 0.510 |
Why?
|
Liver | 4 | 2021 | 7529 | 0.510 |
Why?
|
Dietary Fats | 7 | 2017 | 1995 | 0.510 |
Why?
|
Alcohol Drinking | 5 | 2021 | 4028 | 0.500 |
Why?
|
Nutrition Policy | 2 | 2020 | 471 | 0.500 |
Why?
|
Gastroplasty | 3 | 2003 | 157 | 0.500 |
Why?
|
Female | 94 | 2024 | 392644 | 0.500 |
Why?
|
Humans | 135 | 2024 | 761504 | 0.490 |
Why?
|
Anemia, Iron-Deficiency | 2 | 2019 | 369 | 0.490 |
Why?
|
Fasting | 8 | 2023 | 1603 | 0.490 |
Why?
|
Biological Availability | 3 | 2019 | 390 | 0.460 |
Why?
|
Subcutaneous Fat | 5 | 2021 | 393 | 0.460 |
Why?
|
Proteome | 1 | 2024 | 1862 | 0.460 |
Why?
|
Thermogenesis | 2 | 2016 | 475 | 0.450 |
Why?
|
Risk Reduction Behavior | 2 | 2017 | 1112 | 0.450 |
Why?
|
Subcutaneous Fat, Abdominal | 2 | 2012 | 91 | 0.440 |
Why?
|
Ethanol | 2 | 2021 | 1324 | 0.440 |
Why?
|
Occupational Health | 2 | 2018 | 806 | 0.440 |
Why?
|
Cholesterol, HDL | 11 | 2021 | 1814 | 0.440 |
Why?
|
DNA Methylation | 4 | 2023 | 4398 | 0.430 |
Why?
|
Aging | 5 | 2024 | 8708 | 0.420 |
Why?
|
Pericardium | 1 | 2017 | 675 | 0.420 |
Why?
|
Metabolomics | 2 | 2024 | 1659 | 0.420 |
Why?
|
Feces | 3 | 2024 | 1497 | 0.400 |
Why?
|
Health Promotion | 4 | 2020 | 2214 | 0.400 |
Why?
|
Health Maintenance Organizations | 2 | 2012 | 659 | 0.400 |
Why?
|
Adipose Tissue, White | 1 | 2015 | 365 | 0.400 |
Why?
|
Overweight | 6 | 2024 | 2417 | 0.390 |
Why?
|
Cyclobutanes | 1 | 2011 | 57 | 0.380 |
Why?
|
Insulin Resistance | 9 | 2022 | 3963 | 0.370 |
Why?
|
Pancreas | 1 | 2018 | 1691 | 0.370 |
Why?
|
Iron | 1 | 2019 | 1793 | 0.360 |
Why?
|
Lipoprotein(a) | 2 | 2005 | 480 | 0.350 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 15500 | 0.340 |
Why?
|
Kidney | 2 | 2017 | 7048 | 0.340 |
Why?
|
Adipokines | 1 | 2011 | 310 | 0.330 |
Why?
|
Blood Pressure | 4 | 2018 | 8481 | 0.330 |
Why?
|
Adipose Tissue, Brown | 1 | 2015 | 764 | 0.320 |
Why?
|
Lactones | 1 | 2011 | 317 | 0.320 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2011 | 348 | 0.320 |
Why?
|
Carotid Artery Diseases | 2 | 2018 | 877 | 0.310 |
Why?
|
Diabetic Angiopathies | 4 | 2007 | 803 | 0.310 |
Why?
|
Diet Surveys | 6 | 2010 | 1162 | 0.300 |
Why?
|
Anti-Obesity Agents | 1 | 2011 | 227 | 0.300 |
Why?
|
Energy Metabolism | 3 | 2017 | 2882 | 0.300 |
Why?
|
Cell Adhesion Molecules | 2 | 2020 | 1600 | 0.290 |
Why?
|
Nutritive Value | 3 | 2021 | 350 | 0.290 |
Why?
|
Food | 3 | 2014 | 774 | 0.260 |
Why?
|
Leptin | 2 | 2011 | 1597 | 0.260 |
Why?
|
Cross-Over Studies | 2 | 2024 | 2078 | 0.260 |
Why?
|
C-Reactive Protein | 7 | 2023 | 3826 | 0.260 |
Why?
|
Atherosclerosis | 4 | 2019 | 3408 | 0.250 |
Why?
|
Patient Compliance | 5 | 2015 | 2690 | 0.250 |
Why?
|
Calorimetry, Indirect | 2 | 2016 | 174 | 0.250 |
Why?
|
Brain | 5 | 2024 | 27112 | 0.240 |
Why?
|
Cholesterol | 4 | 2011 | 2904 | 0.240 |
Why?
|
Epigenomics | 2 | 2021 | 943 | 0.240 |
Why?
|
Homocysteine | 2 | 2004 | 638 | 0.240 |
Why?
|
Follow-Up Studies | 20 | 2021 | 39106 | 0.240 |
Why?
|
Omentum | 5 | 2016 | 168 | 0.240 |
Why?
|
MAP Kinase Kinase Kinase 5 | 2 | 2017 | 20 | 0.230 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 691 | 0.230 |
Why?
|
Food Labeling | 2 | 2020 | 179 | 0.230 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2005 | 344 | 0.230 |
Why?
|
Hypertension | 3 | 2015 | 8540 | 0.220 |
Why?
|
Arabs | 4 | 2010 | 187 | 0.220 |
Why?
|
Food Analysis | 1 | 2003 | 103 | 0.210 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 393 | 0.200 |
Why?
|
MicroRNAs | 3 | 2022 | 3816 | 0.200 |
Why?
|
Chin | 1 | 2021 | 38 | 0.190 |
Why?
|
Alanine Transaminase | 3 | 2016 | 603 | 0.190 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4948 | 0.190 |
Why?
|
Medication Adherence | 2 | 2018 | 2176 | 0.180 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2020 | 67 | 0.180 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 33 | 0.180 |
Why?
|
Aspartate Aminotransferases | 2 | 2016 | 416 | 0.180 |
Why?
|
Metagenome | 1 | 2024 | 450 | 0.180 |
Why?
|
Treatment Outcome | 14 | 2022 | 64680 | 0.180 |
Why?
|
Thyrotropin | 1 | 2023 | 834 | 0.170 |
Why?
|
Adiponectin | 4 | 2016 | 1113 | 0.170 |
Why?
|
Aged | 30 | 2024 | 169289 | 0.170 |
Why?
|
Inflammation | 6 | 2024 | 10773 | 0.170 |
Why?
|
Plants, Edible | 1 | 2019 | 30 | 0.170 |
Why?
|
Hypercholesterolemia | 2 | 2003 | 1141 | 0.160 |
Why?
|
Yogurt | 1 | 2019 | 71 | 0.160 |
Why?
|
Creatinine | 2 | 2016 | 1899 | 0.160 |
Why?
|
Satiation | 1 | 2019 | 83 | 0.160 |
Why?
|
Aquatic Organisms | 1 | 2019 | 42 | 0.160 |
Why?
|
Amino Acids, Essential | 1 | 2018 | 26 | 0.160 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3249 | 0.160 |
Why?
|
Sex Factors | 5 | 2022 | 10552 | 0.160 |
Why?
|
Body Composition | 4 | 2021 | 2426 | 0.160 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3802 | 0.160 |
Why?
|
Propionates | 1 | 2019 | 183 | 0.150 |
Why?
|
Iron, Dietary | 1 | 2019 | 148 | 0.150 |
Why?
|
Jews | 5 | 2008 | 356 | 0.150 |
Why?
|
Nutrition Surveys | 3 | 2009 | 1733 | 0.150 |
Why?
|
Genotype | 4 | 2018 | 12990 | 0.150 |
Why?
|
Adipocytes | 2 | 2016 | 1194 | 0.140 |
Why?
|
Regression Analysis | 7 | 2014 | 6343 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 296 | 0.140 |
Why?
|
Cholesterol, LDL | 5 | 2015 | 2382 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2018 | 174 | 0.140 |
Why?
|
Dietary Proteins | 5 | 2022 | 952 | 0.140 |
Why?
|
Atrophy | 1 | 2022 | 1633 | 0.140 |
Why?
|
Glucagon | 1 | 2019 | 532 | 0.140 |
Why?
|
Neck | 1 | 2021 | 734 | 0.140 |
Why?
|
Glucose Intolerance | 1 | 2021 | 575 | 0.140 |
Why?
|
Phylogeny | 1 | 2024 | 2811 | 0.140 |
Why?
|
Cohort Studies | 13 | 2024 | 41487 | 0.140 |
Why?
|
Risk Factors | 15 | 2021 | 74206 | 0.130 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1069 | 0.130 |
Why?
|
CpG Islands | 1 | 2021 | 1230 | 0.130 |
Why?
|
Fruit | 4 | 2014 | 1160 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2011 | 1651 | 0.130 |
Why?
|
Endocrine Glands | 1 | 2016 | 102 | 0.130 |
Why?
|
Health Personnel | 2 | 2009 | 3335 | 0.130 |
Why?
|
Primary Health Care | 1 | 2012 | 4686 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2023 | 1819 | 0.130 |
Why?
|
Dietetics | 2 | 2009 | 34 | 0.130 |
Why?
|
Caloric Restriction | 1 | 2018 | 299 | 0.130 |
Why?
|
Autophagy | 2 | 2016 | 1326 | 0.130 |
Why?
|
Postmenopause | 1 | 2004 | 2513 | 0.130 |
Why?
|
Nuts | 1 | 2017 | 264 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2011 | 4016 | 0.120 |
Why?
|
Education | 1 | 2018 | 537 | 0.120 |
Why?
|
Thigh | 1 | 2016 | 241 | 0.120 |
Why?
|
Apolipoprotein A-I | 3 | 2011 | 299 | 0.120 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3889 | 0.120 |
Why?
|
Zinc | 2 | 2018 | 690 | 0.120 |
Why?
|
Uric Acid | 1 | 2020 | 807 | 0.120 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2014 | 113 | 0.110 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2192 | 0.110 |
Why?
|
Time Factors | 7 | 2017 | 39967 | 0.110 |
Why?
|
Diet Therapy | 1 | 2014 | 151 | 0.110 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 244 | 0.110 |
Why?
|
Endocrine System Diseases | 1 | 2016 | 249 | 0.110 |
Why?
|
Measles-Mumps-Rubella Vaccine | 2 | 2004 | 72 | 0.110 |
Why?
|
Metabolism | 1 | 2014 | 193 | 0.110 |
Why?
|
Lipoproteins, HDL | 1 | 2018 | 676 | 0.110 |
Why?
|
Foam Cells | 1 | 2013 | 68 | 0.110 |
Why?
|
Dairy Products | 3 | 2014 | 490 | 0.100 |
Why?
|
Testosterone | 1 | 2023 | 2472 | 0.100 |
Why?
|
Patient Satisfaction | 2 | 2003 | 3461 | 0.100 |
Why?
|
Bone Marrow | 1 | 2023 | 2911 | 0.100 |
Why?
|
Apolipoprotein B-100 | 3 | 2011 | 157 | 0.100 |
Why?
|
Multivariate Analysis | 7 | 2011 | 12059 | 0.100 |
Why?
|
Phenotype | 3 | 2017 | 16591 | 0.100 |
Why?
|
Risk | 5 | 2016 | 9610 | 0.100 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4431 | 0.100 |
Why?
|
Vegetables | 2 | 2011 | 1195 | 0.100 |
Why?
|
Macrophages | 3 | 2016 | 5769 | 0.100 |
Why?
|
Copper | 1 | 2014 | 369 | 0.100 |
Why?
|
Health Status | 2 | 2021 | 4077 | 0.100 |
Why?
|
Retinol-Binding Proteins | 1 | 2011 | 67 | 0.100 |
Why?
|
Selenium | 1 | 2014 | 417 | 0.100 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2015 | 540 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18252 | 0.100 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 413 | 0.090 |
Why?
|
Magnesium | 1 | 2014 | 804 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2254 | 0.090 |
Why?
|
Carbohydrates | 1 | 2013 | 390 | 0.090 |
Why?
|
Kidney Function Tests | 1 | 2013 | 678 | 0.090 |
Why?
|
Nutrition Disorders | 2 | 2003 | 205 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2872 | 0.090 |
Why?
|
Folic Acid | 3 | 2010 | 1323 | 0.090 |
Why?
|
Serpins | 1 | 2011 | 247 | 0.090 |
Why?
|
Self-Assessment | 1 | 2012 | 396 | 0.090 |
Why?
|
Dietary Fats, Unsaturated | 2 | 2008 | 224 | 0.090 |
Why?
|
Tunica Media | 1 | 2010 | 112 | 0.080 |
Why?
|
Bread | 1 | 2009 | 23 | 0.080 |
Why?
|
Amino Acids | 1 | 2016 | 1718 | 0.080 |
Why?
|
Health Surveys | 2 | 2018 | 4061 | 0.080 |
Why?
|
Diabetes Mellitus | 3 | 2018 | 5840 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2578 | 0.080 |
Why?
|
Albuminuria | 1 | 2013 | 657 | 0.080 |
Why?
|
Body Weight | 3 | 2015 | 4618 | 0.080 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2009 | 149 | 0.080 |
Why?
|
Workplace | 2 | 2012 | 863 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2024 | 1039 | 0.080 |
Why?
|
Meat | 1 | 2011 | 584 | 0.080 |
Why?
|
Organizational Culture | 1 | 2012 | 508 | 0.080 |
Why?
|
Adolescent | 3 | 2020 | 88319 | 0.080 |
Why?
|
Homeostasis | 1 | 2019 | 3323 | 0.070 |
Why?
|
Up-Regulation | 1 | 2017 | 4124 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8181 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2016 | 10209 | 0.070 |
Why?
|
Tunica Intima | 1 | 2010 | 459 | 0.070 |
Why?
|
Databases, Factual | 1 | 2003 | 7967 | 0.070 |
Why?
|
Quality of Life | 3 | 2015 | 13367 | 0.070 |
Why?
|
Calcium, Dietary | 1 | 2010 | 529 | 0.070 |
Why?
|
Ketones | 1 | 2008 | 184 | 0.070 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 441 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15266 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2017 | 26125 | 0.070 |
Why?
|
Diet Records | 2 | 2010 | 427 | 0.070 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2011 | 452 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2570 | 0.070 |
Why?
|
Spouses | 1 | 2009 | 283 | 0.070 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2022 | 269 | 0.070 |
Why?
|
United States Department of Agriculture | 2 | 2003 | 47 | 0.070 |
Why?
|
Apolipoproteins B | 2 | 2006 | 386 | 0.070 |
Why?
|
Incidence | 4 | 2011 | 21353 | 0.070 |
Why?
|
Animals | 8 | 2020 | 168459 | 0.070 |
Why?
|
Self Concept | 1 | 2012 | 1045 | 0.070 |
Why?
|
Insulin | 3 | 2022 | 6596 | 0.070 |
Why?
|
Comprehension | 1 | 2011 | 621 | 0.070 |
Why?
|
Lipid Metabolism | 2 | 2019 | 1902 | 0.070 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 687 | 0.060 |
Why?
|
Young Adult | 5 | 2020 | 59243 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2010 | 941 | 0.060 |
Why?
|
Smoking | 4 | 2009 | 9053 | 0.060 |
Why?
|
Hypertriglyceridemia | 1 | 2008 | 293 | 0.060 |
Why?
|
Testicular Hormones | 1 | 2005 | 188 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6228 | 0.060 |
Why?
|
Survival | 1 | 2005 | 161 | 0.060 |
Why?
|
Linear Models | 2 | 2011 | 5871 | 0.060 |
Why?
|
Fibrinogen | 2 | 2005 | 888 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2176 | 0.060 |
Why?
|
Self Disclosure | 1 | 2005 | 249 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2426 | 0.060 |
Why?
|
Odds Ratio | 2 | 2011 | 9646 | 0.060 |
Why?
|
Thiamine | 1 | 2004 | 160 | 0.060 |
Why?
|
China | 2 | 2024 | 2369 | 0.050 |
Why?
|
beta Carotene | 1 | 2005 | 523 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2005 | 457 | 0.050 |
Why?
|
Eating | 2 | 2008 | 1539 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2006 | 642 | 0.050 |
Why?
|
Rats | 1 | 2019 | 23742 | 0.050 |
Why?
|
Minority Groups | 1 | 2010 | 1203 | 0.050 |
Why?
|
Antibody Formation | 2 | 2004 | 1395 | 0.050 |
Why?
|
Infant | 3 | 2023 | 36192 | 0.050 |
Why?
|
Endpoint Determination | 1 | 2005 | 590 | 0.050 |
Why?
|
Prospective Studies | 5 | 2011 | 54425 | 0.050 |
Why?
|
United States | 7 | 2024 | 72334 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 585 | 0.050 |
Why?
|
Sex Characteristics | 2 | 2010 | 2639 | 0.050 |
Why?
|
Nurses | 2 | 2009 | 2478 | 0.050 |
Why?
|
Mice | 5 | 2020 | 81525 | 0.050 |
Why?
|
Evaluation Studies as Topic | 1 | 2003 | 1624 | 0.050 |
Why?
|
Myocardial Infarction | 4 | 2011 | 11460 | 0.050 |
Why?
|
Information Systems | 1 | 2003 | 396 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 80 | 0.050 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2024 | 467 | 0.050 |
Why?
|
Ovary | 1 | 2005 | 959 | 0.050 |
Why?
|
Military Personnel | 1 | 2010 | 1246 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2004 | 1572 | 0.050 |
Why?
|
Mental Recall | 2 | 2005 | 1214 | 0.040 |
Why?
|
Health Behavior | 2 | 2009 | 2643 | 0.040 |
Why?
|
Central Nervous System Depressants | 1 | 2021 | 164 | 0.040 |
Why?
|
Quality Control | 1 | 2003 | 832 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2005 | 1336 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2010 | 4471 | 0.040 |
Why?
|
Attitude to Health | 1 | 2009 | 2025 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14605 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2003 | 397 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 23995 | 0.040 |
Why?
|
Logistic Models | 2 | 2011 | 13255 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2023 | 80636 | 0.040 |
Why?
|
Exercise Test | 1 | 2007 | 2127 | 0.040 |
Why?
|
Breast Diseases | 1 | 2003 | 442 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2005 | 1675 | 0.040 |
Why?
|
Deficiency Diseases | 1 | 2000 | 74 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2021 | 283 | 0.040 |
Why?
|
Comorbidity | 2 | 2011 | 10508 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2243 | 0.040 |
Why?
|
Glycogen | 1 | 2019 | 251 | 0.040 |
Why?
|
Disease Progression | 2 | 2018 | 13506 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2017 | 22176 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2017 | 12795 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2005 | 20098 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2019 | 518 | 0.040 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2000 | 295 | 0.040 |
Why?
|
Family Practice | 1 | 2000 | 512 | 0.040 |
Why?
|
Postoperative Period | 1 | 2002 | 1813 | 0.040 |
Why?
|
Glycoproteins | 1 | 2005 | 2203 | 0.040 |
Why?
|
Fertilization in Vitro | 1 | 2005 | 1292 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3422 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2017 | 178 | 0.030 |
Why?
|
Metabolome | 1 | 2024 | 989 | 0.030 |
Why?
|
Ultrasonography | 1 | 2010 | 5972 | 0.030 |
Why?
|
Vitamin D | 1 | 2010 | 3303 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2005 | 1376 | 0.030 |
Why?
|
Stomach | 1 | 2020 | 696 | 0.030 |
Why?
|
Social Class | 1 | 2005 | 2004 | 0.030 |
Why?
|
Louisiana | 1 | 2016 | 103 | 0.030 |
Why?
|
Amino Acids, Aromatic | 1 | 2016 | 36 | 0.030 |
Why?
|
Educational Status | 3 | 2011 | 2522 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6567 | 0.030 |
Why?
|
Registries | 1 | 2011 | 8224 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 522 | 0.030 |
Why?
|
Anthropometry | 2 | 2013 | 1349 | 0.030 |
Why?
|
Fabaceae | 1 | 2014 | 103 | 0.030 |
Why?
|
Sample Size | 1 | 2018 | 841 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6377 | 0.030 |
Why?
|
Calcinosis | 1 | 2003 | 1469 | 0.030 |
Why?
|
Breast | 1 | 2003 | 1967 | 0.030 |
Why?
|
Language | 1 | 2003 | 1540 | 0.030 |
Why?
|
Nutrition Assessment | 2 | 2010 | 728 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2199 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22169 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2023 | 1879 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2781 | 0.030 |
Why?
|
Physical Fitness | 1 | 1998 | 743 | 0.030 |
Why?
|
Trace Elements | 1 | 2014 | 195 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2850 | 0.030 |
Why?
|
Africa | 1 | 2014 | 709 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22170 | 0.030 |
Why?
|
Lanosterol | 1 | 2011 | 2 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2016 | 1341 | 0.020 |
Why?
|
Phytosterols | 1 | 2011 | 55 | 0.020 |
Why?
|
Fishes | 1 | 2014 | 603 | 0.020 |
Why?
|
Physicians | 1 | 2009 | 4591 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3683 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2000 | 2319 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4346 | 0.020 |
Why?
|
Cell Movement | 2 | 2016 | 5203 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2901 | 0.020 |
Why?
|
Tissue Banks | 1 | 2010 | 184 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3058 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18965 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4936 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2919 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29874 | 0.020 |
Why?
|
Age Distribution | 2 | 2005 | 2880 | 0.020 |
Why?
|
Nutritional Status | 2 | 2009 | 1615 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4278 | 0.020 |
Why?
|
Morbidity | 1 | 2013 | 1750 | 0.020 |
Why?
|
Stromal Cells | 1 | 2013 | 1330 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 7390 | 0.020 |
Why?
|
Phagocytosis | 1 | 2013 | 1528 | 0.020 |
Why?
|
Biopsy | 2 | 2010 | 6766 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2669 | 0.020 |
Why?
|
Cluster Analysis | 2 | 2005 | 2707 | 0.020 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2010 | 389 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1738 | 0.020 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2007 | 186 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 615 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2010 | 561 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2018 | 1533 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2469 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 598 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5869 | 0.020 |
Why?
|
Cardiovascular System | 1 | 2013 | 834 | 0.020 |
Why?
|
Appetite Depressants | 1 | 2005 | 108 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 605 | 0.010 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7827 | 0.010 |
Why?
|
Minerals | 1 | 2005 | 283 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2010 | 908 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 2004 | 238 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3597 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5035 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7581 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 2005 | 407 | 0.010 |
Why?
|
Lymphocyte Activation | 2 | 2004 | 5486 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9326 | 0.010 |
Why?
|
Antibodies, Viral | 2 | 2004 | 3156 | 0.010 |
Why?
|
Prediabetic State | 1 | 2008 | 545 | 0.010 |
Why?
|
Transients and Migrants | 1 | 2005 | 165 | 0.010 |
Why?
|
Immunization Schedule | 1 | 2003 | 227 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 2004 | 4544 | 0.010 |
Why?
|
Translating | 1 | 2003 | 143 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2009 | 1403 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2036 | 0.010 |
Why?
|
Immunization, Secondary | 1 | 2003 | 367 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2004 | 1596 | 0.010 |
Why?
|
Lipoproteins | 1 | 2004 | 881 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2281 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3810 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1988 | 2199 | 0.010 |
Why?
|
Rural Population | 1 | 2009 | 2285 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15936 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4920 | 0.010 |
Why?
|
Antibodies | 1 | 2006 | 2418 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 2005 | 1410 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 2005 | 1089 | 0.010 |
Why?
|
Prevalence | 2 | 2005 | 15732 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8631 | 0.010 |
Why?
|
Vitamins | 1 | 2005 | 1635 | 0.010 |
Why?
|
Patient Selection | 1 | 2008 | 4244 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12128 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2003 | 2696 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2006 | 3113 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9469 | 0.010 |
Why?
|
Age Factors | 2 | 2003 | 18395 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2003 | 1200 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2003 | 2200 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30052 | 0.010 |
Why?
|
Mammography | 1 | 2003 | 2430 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14666 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2005 | 12463 | 0.010 |
Why?
|
Mass Screening | 1 | 2003 | 5428 | 0.000 |
Why?
|
Signal Transduction | 1 | 2009 | 23445 | 0.000 |
Why?
|
Prognosis | 1 | 2005 | 29625 | 0.000 |
Why?
|
Child | 2 | 2003 | 80153 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15842 | 0.000 |
Why?
|
South Africa | 1 | 1988 | 1842 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2005 | 58976 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2000 | 26198 | 0.000 |
Why?
|
Child, Preschool | 1 | 2000 | 42230 | 0.000 |
Why?
|